Evidence-Based Strategies for COPD Diagnosis, Management, and Prevention - Episode 5
Treatment of COPD Based on Symptoms
Panelists discuss how chronic obstructive pulmonary disease (COPD) management follows a stepwise approach, beginning with bronchodilators (typically short-acting β2-agonists/long-acting β2-agonists) and progressing to combination therapy with long-acting muscarinic antagonists/inhaled corticosteroids based on symptom severity. Current unmet needs include more targeted anti-inflammatory treatments, better biomarkers for phenotyping, and therapies to halt disease progression, particularly for those who don’t respond well to conventional treatments.
Video content above is prompted by the following:
- What is the typical treatment progression in symptomatic COPD?
- Explain the role of inflammation and discuss the percentage of patients with COPD who have type 2 inflammation.
- What are some of the unmet needs in the treatment of COPD?
